Chemours Co
NYSE:CC

Watchlist Manager
Chemours Co Logo
Chemours Co
NYSE:CC
Watchlist
Price: 16.96 USD -16.9% Market Closed
Market Cap: $2.5B

Chemours Co
Investor Relations

In the ever-evolving landscape of chemical manufacturing, Chemours Co. stands out as a testament to adaptation and innovation. Spun off from DuPont in 2015, Chemours made its mark by inheriting a robust portfolio that included titanium technologies, fluoroproducts, and chemical solutions. With titanium dioxide as a cornerstone of its operations, the company supplies essential pigments that imbue products like coatings and plastics with their vibrant colors and brightness. However, it’s the fluoroproducts segment that tells the more dynamic side of Chemours' story. The division is responsible for producing Teflon and other fluoropolymers, which find their way into countless applications from automotive to electronics. These products not only define durability and non-stick conveniences in daily life but also drive a significant portion of the company's revenue.

Despite the legacy grounding Chemours in proven cash flows, it's the company’s pivot towards sustainability and eco-innovation that paints a compelling portrait of its future. Launching its Opteon line of refrigerants, designed to minimize environmental impact, underscores Chemours’ commitment to leading with green solutions amid a backdrop of global climate concerns. Further pushing the envelope with its “Chemours Future of Chemistry” initiative, the company aims to leverage its scientific prowess to develop products that are not only profitable but sustainable. Operating in this dual role of a traditional powerhouse and a forward-looking innovator, Chemours navigates the complexities of modern chemical demands by aligning profitability with a responsible outlook.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2025
Call Date
Feb 20, 2026
AI Summary
Q4 2025

Record Opteon Sales: Chemours' TSS segment delivered record Opteon refrigerant sales in Q4, up 37% year-over-year and driving strong annual results.

Cash Flow Strength: Quarterly free cash flow reached $92 million, seen as more indicative of long-term potential despite just missing the low end of the earnings range.

Guidance Maintained: Full-year 2026 guidance calls for 3%–5% net sales growth and $800–900 million in adjusted EBITDA, with earnings growth expected in all three segments.

Debt Reduction: Expected $300 million in proceeds from the sale of the Kuan Yin site will be used to reduce debt, aiming for net leverage below 4x by the end of 2026.

Operational Improvements: Cost control, improved pricing, and ongoing restructuring (especially in TT and APM) are expected to underpin better margins and cash generation.

Temporary Headwinds: APM segment faced a significant Q1 plant outage, but operations have resumed and profitability is expected to recover through 2026.

Positive Market Trends: Strong demand seen in data center and semiconductor markets, and regulatory changes continue to boost refrigerants.

Inventory Focus: Management acknowledged excess inventory, especially in TT, and is targeting improvements in 2026.

Key Financials
Free Cash Flow
$92 million
Opteon Refrigerant Sales Growth
56%
TSS Q4 Opteon Sales Growth
37%
TSS Annual Adjusted EBITDA Margin
32%
Q1 2026 Consolidated Net Sales Growth
3% to 5% sequentially
Q1 2026 Consolidated Adjusted EBITDA
$120 million to $150 million
2026 Full Year Net Sales Growth
3% to 5%
2026 Full Year Adjusted EBITDA
$800 million to $900 million
Expected Proceeds from Kuan Yin Site Sale
$300 million
Q1 2026 TSS Net Sales Growth
Mid-20s to 30% sequentially
Q1 2026 TSS Adjusted EBITDA
$170 million to $185 million
Q1 2026 TT Net Sales
Low to mid-single-digit percentage decrease sequentially
Q1 2026 TT Adjusted EBITDA
Breakeven to $5 million
Q1 2026 APM Net Sales
High teens percentage decrease sequentially
Q1 2026 APM Adjusted EBITDA
Breakeven to $5 million
Q1 2026 Corporate Expense
$45 million to $50 million
Q1 2026 Capital Expenditures
$50 million
Q1 2026 Free Cash Flow
Use of cash not to exceed $100 million
2026 Full Year Capital Expenditures
$275 million to $325 million
2025 Gross Controllable Cost Savings
$125 million
Other Earnings Calls

Management

Ms. Denise M. Dignam
President, CEO & Director
No Bio Available
Ms. Kristine M. Wellman
Senior VP, General Counsel & Company Secretary
No Bio Available
Ms. Alvenia Scarborough
Senior VP of Corporate Communications & Chief Brand Officer
No Bio Available
Mr. Shane W. Hostetter CPA
Senior VP & CFO
No Bio Available
Mr. Brandon Ontjes
Vice President of Investor Relations
No Bio Available
Mr. Brian Shay
Interim Chief Human Resources Officer
No Bio Available
Mr. Matthew S. Abbott
Senior VP & Chief Enterprise Transformation Officer
No Bio Available
Mr. Aditya Beri
Interim President of Titanium Technologies & Chemical Solutions Business
No Bio Available
Mr. Gerardo Familiar Calderon
President of Advanced Performance Materials
No Bio Available
Ms. Amber Wellman Ph.D.
Chief Sustainability Officer
No Bio Available

Contacts

Address
DELAWARE
Wilmington
1007 Market St
Contacts
+13027731000.0
www.chemours.com